Association Of Tshr Gene Polymorphism (Rs74067403, Rs1054708 and Rs2268458) In Patients with Graves' Disease in Coastal Andhra Pradesh

Authors

  • V L Swathi Vangipurapu
  • Ch. Bhargavi
  • G. Sudhakar

Abstract

Graves’ disease (GD) is an autoimmune thyroid disorder marked by hyperthyroidism and the presence of thyroid-stimulating hormone receptor (TSHR) autoantibodies. Genetic susceptibility is a key factor in GD pathogenesis, with TSHR gene polymorphisms playing a significant role. This study evaluated the association of three TSHR single nucleotide polymorphisms (SNPs)—rs74067403, rs1054708, and rs2268458—with GD in a population from Coastal Andhra Pradesh, India. A case-control design included 170 confirmed GD patients and 170 age- and sex-matched healthy controls. Genomic DNA was isolated and genotyped using allele-specific PCR. Chi-square tests and odds ratios (OR) with 95% confidence intervals (CI) assessed genotype-disease associations. The rs74067403 AG genotype was significantly associated with increased GD risk (OR = 2.38; 95% CI: 1.18–4.78; p = 0.0145), while the AA genotype appeared protective. The rs2268458 TC genotype showed a strong association with GD (OR = 11.13; p < 0.0001), and the C allele was more frequent among cases. In contrast, rs1054708 was monomorphic (TT) in all participants and showed no disease association. Additionally, both rs74067403 and rs2268458 were significantly associated with remission after radioiodine therapy and orbitopathy in GD patients. Overall, rs74067403 and rs2268458 may serve as potential genetic markers for GD risk in this region, while rs1054708 appears non-contributory. These findings underscore the importance of region-specific genetic studies in understanding autoimmune thyroid disease.

Downloads

Download data is not yet available.

References

Brand, O. J., Barrett, J. C., Simmonds, M. J., Newby, P. R., McCabe, C. J., Gough, S. C., & Franklyn, J. A. (2009). Association of the thyroid-stimulating hormone receptor gene (TSHR) with Graves’ disease. Human Molecular Genetics, 18(9), 1704–1713. https://doi.org/10.1093/hmg/ddp087

Burch, H. B., & Cooper, D. S. (2015). Management of Graves’ disease: A review. JAMA, 314(23), 2544–2554. https://doi.org/10.1001/jama.2015.14735

Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., Eckstein, A. K., Stagnaro-Green, A., & Kahaly, G. J. (2020). Graves’ disease. Nature Reviews Disease Primers, 6(1), 52. https://doi.org/10.1038/s41572-020-0184-y

Grixti, J., et al. (2023). Genetics of autoimmune thyroid diseases: Global insights and local variations. Autoimmunity Reviews, 22(1), 103233. https://doi.org/10.1016/j.autrev.2022.103233

Kahaly, G. J., & Bartalena, L. (2017). The pathogenesis of Graves’ orbitopathy. Thyroid, 27(2), 234–242. https://doi.org/10.1089/thy.2016.0271

Kleinau, G., & Krause, G. (2009). Thyrotropin and homologous glycoprotein hormone receptors: Structural and functional aspects of extracellular ligand binding. Journal of Molecular Recognition, 22(5), 374–384. https://doi.org/10.1002/jmr.948

Kraus, C. N., Sodha, P., Vaidyanathan, P., & Kirkorian, A. Y. (2018). Thyroid dermopathy and acropachy in pediatric patients. Pediatric Dermatology, 35(6), e371–e374. https://doi.org/10.1111/pde.13670

Kuś, A., Chaker, L., Teumer, A., Peeters, R. P., & Medici, M. (2020). The Genetic Basis of Thyroid Function: Novel Findings and New Approaches. The Journal of Clinical Endocrinology & Metabolism, 105(6), dgz225. https://doi.org/10.1210/clinem/dgz225

Lombardi, A., Menconi, F., Greenberg, D., Concepcion, E., & Tomer, Y. (2017). Dissecting the genetic susceptibility to Graves’ disease in a cohort of patients of Italian origin. Frontiers in Endocrinology, 7, 162. https://doi.org/10.3389/fendo.2016.00162

Menconi, F., Marcocci, C., & Marinò, M. (2014). Diagnosis and classification of Graves' disease. Autoimmunity Reviews, 13(4-5), 398–402. https://doi.org/10.1016/j.autrev.2014.01.013

Naghibi, F. S., Miresmaeili, S. M., & Javid, A. (2022). Association of TSHR gene single nucleotide intronic polymorphism with the risk of hypothyroid and hyperthyroid disorders in Yazd province. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-19822-0

Panicker, V., et al. (2008). A common variation in the deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. The Journal of Clinical Endocrinology & Metabolism, 93(8), 3075–3081. https://doi.org/10.1210/jc.2008-0397

Ramgopal, S., Rathika, C., Padma, K. M., Joseph, P. V., & Balakrishnan, K. (2018). Analysis of CTLA4 gene variant and HLA class-II alleles in South Indian patients with autoimmune thyroid disease. Indian Journal of Human Genetics, 24(2), 143–148. https://doi.org/10.4103/ijhg.ijhg_12_18

Taylor, P. N., et al. (2018). Global epidemiology of hyperthyroidism and hypothyroidism. Nature Reviews Endocrinology, 14(5), 301–316. https://doi.org/10.1038/nrendo.2018.18

Tomer, Y., & Huber, A. (2009). The etiology of autoimmune thyroid disease: A story of genes and environment. Journal of Autoimmunity, 32(3-4), 231–239. https://doi.org/10.1016/j.jaut.2009.02.007

Tyagi, S., et al. (2024). Genetic predisposition to thyroid dysfunction: a case–control study investigating TSHR gene polymorphism (rs2268458) in Indians. Egyptian Journal of Medical Human Genetics, 25(1), 129. https://doi.org/10.1186/s43042-024-00592-5

Unnikrishnan, A. G., et al. (2013). Prevalence of hypothyroidism in adults: An epidemiological study in eight cities of India. Indian Journal of Endocrinology and Metabolism, 17(4), 647–652. https://doi.org/10.4103/2230-8210.113755

Wang, C., et al. (2021). Hyperthyroidism prevalence in China after universal salt iodization. Frontiers in Endocrinology, 12, 651534. https://doi.org/10.3389/fendo.2021.651534

Wei, Q., et al. (2016). Association between TSHR gene polymorphism and the risk of Graves’ disease: A meta-analysis. Journal of Biomedical Research, 30(6), 466. https://doi.org/10.7555/jbr.30.20140144

Williams, A. T., et al. (2023). Genome-wide association study of thyroid-stimulating hormone highlights new genes, pathways, and associations with thyroid disease. Nature Communications, 14(1), 6713. https://doi.org/10.1038/s41467-023-42284-5

Wu, D., et al. (2023). Advances in understanding of the pathogenesis and therapeutic strategies of Graves’ disease: A comprehensive review. Frontiers in Endocrinology, 14, 1129347. https://doi.org/10.3389/fendo.2023.1129347

Zaaber, I. (2020). Polymorphisms in the TSHR gene and the risk and prognosis of autoimmune thyroid disease in the Tunisian population. Acta Endocrinologica (Bucharest), 16(1), 1–8. https://doi.org/10.4183/aeb.2020.1

Downloads

Published

2025-05-27

How to Cite

1.
Vangipurapu VLS, Bhargavi C, Sudhakar G. Association Of Tshr Gene Polymorphism (Rs74067403, Rs1054708 and Rs2268458) In Patients with Graves’ Disease in Coastal Andhra Pradesh. J Neonatal Surg [Internet]. 2025 May 27 [cited 2025 Dec. 13];14(8):445-54. Available from: https://jneonatalsurg.com/index.php/jns/article/view/6625

Most read articles by the same author(s)